Pr Staels - Genfit SA CoFounder Board
| GNFT Stock | USD 3.55 0.02 0.57% |
Insider
Pr Staels is CoFounder Board of Genfit SA
| Age | 62 |
| Address | Parc EurasantE, Loos, France, 59120 |
| Phone | 33 3 20 16 40 00 |
| Web | https://www.genfit.com |
Genfit SA Management Efficiency
The company has return on total asset (ROA) of (0.0856) % which means that it has lost $0.0856 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5174) %, meaning that it created substantial loss on money invested by shareholders. Genfit SA's management efficiency ratios could be used to measure how well Genfit SA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Andrew Slee | Protagenic Therapeutics | 75 | |
| Anna Moore | Transcode Therapeutics | 63 | |
| Qiyong Liu | Transcode Therapeutics | 60 | |
| Rasmus HolmJorgensen | Acrivon Therapeutics, Common | 53 | |
| Kristina Masson | Acrivon Therapeutics, Common | 44 | |
| Eric Devroe | Acrivon Therapeutics, Common | 46 | |
| Adam MD | NervGen Pharma Corp | N/A | |
| Crystal Mercado | Acrivon Therapeutics, Common | N/A | |
| Robert MD | Protagenic Therapeutics | 74 | |
| Matthew Lowell | Alpha Teknova | 55 | |
| Harold DMD | NervGen Pharma Corp | N/A | |
| Damon Terrill | Alpha Teknova | 53 | |
| Peter MD | Acrivon Therapeutics, Common | 62 | |
| Brian McAlister | NervGen Pharma Corp | N/A | |
| Jesper Olsen | Acrivon Therapeutics, Common | N/A | |
| Rex CFA | Anebulo Pharmaceuticals | 64 | |
| Erick MD | Acrivon Therapeutics, Common | 67 | |
| Ken Gelhaus | Alpha Teknova | 40 | |
| David Lovejoy | Protagenic Therapeutics | N/A | |
| William BASc | NervGen Pharma Corp | 60 | |
| Scott Anderson | Anebulo Pharmaceuticals | N/A | |
Management Performance
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.0856 |
Genfit SA Leadership Team
Elected by the shareholders, the Genfit SA's board of directors comprises two types of representatives: Genfit SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genfit. The board's role is to monitor Genfit SA's management team and ensure that shareholders' interests are well served. Genfit SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genfit SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stefanie JD, Chief Affairs | ||
| Pascal Caisey, Chief Officer | ||
| Sakina SayahJeanne, Executive Science | ||
| Dean Hum, COO, Chief Scientific Officer, Member of the Management Board | ||
| Thomas Baetz, Chief Officer | ||
| Pr Staels, CoFounder Board | ||
| JeanChristophe Marcoux, Chief Officer | ||
| Meriam Kabbaj, Chief Officer | ||
| Pascal Prigent, Chief Officer | ||
| Laurent Lannoo, Corporate Affairs | ||
| JeanFrancois Mouney, Chairman of the Management Board, CEO | ||
| John Brozek, Executive Technology | ||
| Stefanie Magner, Chief Affairs | ||
| Emilie Desodt, Executive Resources |
Genfit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genfit SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.0856 | ||||
| Profit Margin | (0.86) % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 65.67 M | ||||
| Shares Outstanding | 50 M | ||||
| Shares Owned By Institutions | 0.16 % | ||||
| Number Of Shares Shorted | 30.66 K | ||||
| Price To Earning | 4.72 X | ||||
| Price To Book | 2.88 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Genfit Stock Analysis
When running Genfit SA's price analysis, check to measure Genfit SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genfit SA is operating at the current time. Most of Genfit SA's value examination focuses on studying past and present price action to predict the probability of Genfit SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genfit SA's price. Additionally, you may evaluate how the addition of Genfit SA to your portfolios can decrease your overall portfolio volatility.